S&P 500   3,819.83 (-1.30%)
DOW   31,272.44 (-0.38%)
QQQ   310.14 (-2.59%)
AAPL   122.59 (-2.02%)
MSFT   227.80 (-2.60%)
FB   256.48 (-0.97%)
GOOGL   2,018.92 (-2.21%)
TSLA   657.50 (-4.22%)
AMZN   3,015.43 (-2.56%)
NVDA   513.69 (-4.21%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.80 (-1.42%)
NIO   41.23 (-4.76%)
AMD   81.23 (-3.45%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.73 (-4.58%)
PFE   34.34 (+2.48%)
S&P 500   3,819.83 (-1.30%)
DOW   31,272.44 (-0.38%)
QQQ   310.14 (-2.59%)
AAPL   122.59 (-2.02%)
MSFT   227.80 (-2.60%)
FB   256.48 (-0.97%)
GOOGL   2,018.92 (-2.21%)
TSLA   657.50 (-4.22%)
AMZN   3,015.43 (-2.56%)
NVDA   513.69 (-4.21%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.80 (-1.42%)
NIO   41.23 (-4.76%)
AMD   81.23 (-3.45%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.73 (-4.58%)
PFE   34.34 (+2.48%)
S&P 500   3,819.83 (-1.30%)
DOW   31,272.44 (-0.38%)
QQQ   310.14 (-2.59%)
AAPL   122.59 (-2.02%)
MSFT   227.80 (-2.60%)
FB   256.48 (-0.97%)
GOOGL   2,018.92 (-2.21%)
TSLA   657.50 (-4.22%)
AMZN   3,015.43 (-2.56%)
NVDA   513.69 (-4.21%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.80 (-1.42%)
NIO   41.23 (-4.76%)
AMD   81.23 (-3.45%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.73 (-4.58%)
PFE   34.34 (+2.48%)
S&P 500   3,819.83 (-1.30%)
DOW   31,272.44 (-0.38%)
QQQ   310.14 (-2.59%)
AAPL   122.59 (-2.02%)
MSFT   227.80 (-2.60%)
FB   256.48 (-0.97%)
GOOGL   2,018.92 (-2.21%)
TSLA   657.50 (-4.22%)
AMZN   3,015.43 (-2.56%)
NVDA   513.69 (-4.21%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.80 (-1.42%)
NIO   41.23 (-4.76%)
AMD   81.23 (-3.45%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.73 (-4.58%)
PFE   34.34 (+2.48%)
Log in
OTCMKTS:ABAHF

Abacus Health Products Competitors

$4.84
-0.26 (-5.10 %)
(As of 06/11/2020)
Add
Compare
Today's Range
$4.60
Now: $4.84
$5.50
50-Day Range
$4.84
MA: $4.84
$4.84
52-Week Range
$1.12
Now: $4.84
$8.40
Volume9,300 shs
Average Volume10,164 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Abacus Health Products (OTCMKTS:ABAHF) Vs. ACRGF, APPB, AYRSF, CANB, CNTMF, and CWBHF

Should you be buying ABAHF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Abacus Health Products, including Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), Cansortium (CNTMF), and Charlotte's Web (CWBHF).

Abacus Health Products (OTCMKTS:ABAHF) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation and analyst recommendations.

Profitability

This table compares Abacus Health Products and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
AcreageN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for Abacus Health Products and Acreage, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
Acreage01202.67

Acreage has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher probable upside, analysts plainly believe Acreage is more favorable than Abacus Health Products.

Valuation and Earnings

This table compares Abacus Health Products and Acreage's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Summary

Acreage beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Profitability

This table compares Applied Biosciences and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for Applied Biosciences and Abacus Health Products, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Abacus Health Products0000N/A

Valuation and Earnings

This table compares Applied Biosciences and Abacus Health Products' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Ayr Strategies (OTCMKTS:AYRSF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Valuation and Earnings

This table compares Ayr Strategies and Abacus Health Products' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ayr StrategiesN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for Ayr Strategies and Abacus Health Products, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ayr Strategies01602.86
Abacus Health Products0000N/A

Ayr Strategies presently has a consensus target price of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher probable upside, equities research analysts plainly believe Ayr Strategies is more favorable than Abacus Health Products.

Profitability

This table compares Ayr Strategies and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ayr StrategiesN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Summary

Ayr Strategies beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Abacus Health Products (OTCMKTS:ABAHF) and Can B (NASDAQ:CANB) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Valuation & Earnings

This table compares Abacus Health Products and Can B's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
Can BN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Abacus Health Products and Can B, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
Can B0000N/A

Profitability

This table compares Abacus Health Products and Can B's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
Can BN/AN/AN/A

Abacus Health Products (OTCMKTS:ABAHF) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Profitability

This table compares Abacus Health Products and Cansortium's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
CansortiumN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Abacus Health Products and Cansortium, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
Cansortium00103.00

Cansortium has a consensus target price of $1.20, suggesting a potential upside of 49.16%. Given Cansortium's higher probable upside, analysts plainly believe Cansortium is more favorable than Abacus Health Products.

Valuation & Earnings

This table compares Abacus Health Products and Cansortium's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
CansortiumN/AN/AN/AN/AN/A

Summary

Cansortium beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Charlotte's Web (OTCMKTS:CWBHF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, profitability and risk.

Profitability

This table compares Charlotte's Web and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Charlotte's WebN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Charlotte's Web and Abacus Health Products, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Charlotte's Web01402.80
Abacus Health Products0000N/A

Charlotte's Web presently has a consensus price target of $7.80, suggesting a potential upside of 61.32%. Given Charlotte's Web's higher possible upside, equities research analysts clearly believe Charlotte's Web is more favorable than Abacus Health Products.

Valuation and Earnings

This table compares Charlotte's Web and Abacus Health Products' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charlotte's WebN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Summary

Charlotte's Web beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.


Abacus Health Products Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Acreage logo
ACRGF
Acreage
1.2$2.77-0.0%$0.00N/A0.00
APPB
Applied Biosciences
0.5$0.16-0.0%$0.00N/A0.00Increase in Short Interest
AYRSF
Ayr Strategies
1.4$21.26-0.0%$0.00N/A0.00News Coverage
CANB
Can B
0.4$0.59-15.3%$0.00N/A0.00High Trading Volume
CNTMF
Cansortium
1.1$0.80-7.5%$0.00N/A0.00Decrease in Short Interest
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.84-1.9%$0.00N/A0.00Decrease in Short Interest
Gap Down
CHOOF
Choom
0.5$0.12-8.3%$0.00N/A0.00Increase in Short Interest
News Coverage
CPHRF
Cipher Pharmaceuticals
1.2$0.72-4.2%$0.00N/A0.00Increase in Short Interest
Gap Up
CLSH
CLS Holdings USA
0.7$0.27-11.1%$0.00N/A0.00Decrease in Short Interest
Gap Up
COSM
Cosmos
0.5$4.78-0.0%$0.00N/A0.00Increase in Short Interest
Cresco Labs logo
CRLBF
Cresco Labs
1.5$15.01-4.3%$0.00N/A0.00Decrease in Short Interest
Curaleaf logo
CURLF
Curaleaf
1.6$17.01-1.5%$0.00N/A0.00Decrease in Short Interest
Gap Down
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
EAPH
Easton Pharmaceuticals
0.5$0.00-0.0%$0.00N/A0.00
ELLXF
Elixinol Global
0.8$0.16-6.3%$0.00N/A0.00Increase in Short Interest
EVIO
EVIO
0.6$0.00-0.0%$0.00N/A0.00
FLOOF
Flower One
0.4$0.26-3.8%$0.00N/A0.00Increase in Short Interest
News Coverage
GLDFF
Golden Leaf
0.5$0.06-0.0%$0.00N/A0.00Increase in Short Interest
Gap Down
GGBXF
Green Growth Brands
0.4$0.04-23.4%$0.00N/A0.00Gap Down
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.5$35.59-5.9%$0.00N/A0.00
GGTTF
GTEC
0.6$0.67-11.9%$0.00N/A0.00High Trading Volume
Increase in Short Interest
Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$4.02-3.2%$0.00N/A0.00Decrease in Short Interest
Gap Down
HPMM
Hemp Naturals
0.6$0.01-0.0%$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6N/AN/A$0.00N/A0.00
HKMPY
Hikma Pharmaceuticals
0.4$66.83-0.0%$0.00N/A0.00
ITHUF
iAnthus Capital
0.6$0.31-3.2%$0.00N/A0.00Gap Down
ICNAF
Icanic Brands
0.6$0.49-0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.05-0.0%$0.00N/A0.00Decrease in Short Interest
ISOLF
Isodiol International
0.4$0.09-0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
KHRNF
Khiron Life Sciences
1.4$0.41-12.1%$0.00N/A0.00Increase in Short Interest
KHTRF
Knight Therapeutics
1.2$4.07-0.2%$0.00N/A0.00Decrease in Short Interest
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.07-14.3%$0.00N/A0.00Decrease in Short Interest
Gap Up
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.44-20.6%$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.40-17.5%$0.00N/A0.00Decrease in Short Interest
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$32.71-0.5%$0.00N/A0.00High Trading Volume
MJARF
MJardin Group
0.7$0.12-8.3%$0.00N/A0.00Increase in Short Interest
Gap Up
MYHI
Mountain High Acquisitions
0.5$0.03-0.0%$0.00N/A0.00Decrease in Short Interest
Gap Down
PHCEF
Pharmacielo
0.7$2.08-3.4%$0.00N/A0.00
PLPRF
Plus Products
1.1$0.79-1.3%$0.00N/A0.00Increase in Short Interest
Gap Up
BIEI
Premier Biomedical
0.5$0.00-0.0%$0.00N/A0.00
PCYN
Procyon
0.4$0.78-0.0%$0.00N/A0.00Decrease in Short Interest
PRCNF
Pure Global Cannabis
0.7$0.03-0.0%$0.00N/A0.00Decrease in Short Interest
SANP
Santo Mining
0.5$0.01-0.0%$0.00N/A0.00High Trading Volume
Gap Down
SGIOY
Shionogi & Co., Ltd.
0.5$12.91-0.5%$0.00N/A0.00Increase in Short Interest
DNPUF
Sumitomo Dainippon Pharma
0.5$16.50-0.0%$0.00N/A0.00
TerrAscend logo
TRSSF
TerrAscend
1.7$13.69-1.9%$0.00N/A0.00Increase in Short Interest
The Flowr logo
FLWPF
The Flowr
1.5$0.29-3.4%$0.00N/A0.00
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.2$0.23-0.0%$0.00N/A0.00
This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.